XML 53 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 4 Months Ended 8 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Apr. 22, 2016
Dec. 31, 2016
Predecessor [Member]        
Basic EPS:        
Net Income (Loss)   $ (108,303) $ 851,611  
Income, share amounts   44,672    
Earnings Per Share, Basic   $ (2.42)    
Dilutive Securities:        
Dilutive RSAs   0    
Dilutive RSUs   0    
Dilutive Stock Options   0    
Diluted EPS:        
Net Income (Loss) Available to Common Stockholders, Diluted   $ (108,303)    
Weighted Average Number of Shares Outstanding, Diluted   44,672    
Earnings Per Share, Diluted   $ (2.42)    
Predecessor [Member] | Stock Options [Member]        
Earnings Per Share (Textual)        
Antidilutive shares excluded from EPS, shares   1,300    
Predecessor [Member] | Restricted Stock [Member]        
Earnings Per Share (Textual)        
Antidilutive shares excluded from EPS, shares   300    
Predecessor [Member] | Restricted Stock Units (RSUs) [Member]        
Earnings Per Share (Textual)        
Antidilutive shares excluded from EPS, shares   800    
Successor [Member]        
Basic EPS:        
Net Income (Loss) $ 17,710     $ (156,288)
Income, share amounts 11,232      
Earnings Per Share, Basic $ 1.58      
Dilutive Securities:        
Dilutive RSAs 0      
Dilutive RSUs 76      
Dilutive Stock Options 15      
Diluted EPS:        
Net Income (Loss) Available to Common Stockholders, Diluted $ 17,710      
Weighted Average Number of Shares Outstanding, Diluted 11,323      
Earnings Per Share, Diluted $ 1.57      
Successor [Member] | Stock Options [Member]        
Earnings Per Share (Textual)        
Antidilutive shares excluded from EPS, shares 400      
Successor [Member] | Restricted Stock Units (RSUs) [Member]        
Earnings Per Share (Textual)        
Antidilutive shares excluded from EPS, shares 100      
Warrant [Member] | Successor [Member]        
Earnings Per Share (Textual)        
Antidilutive shares excluded from EPS, shares 4,300